Shiatsu for Chronic Non-Inflammatory Pain in Children and Adolescents

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-18
SponsorTel Aviv University

About this trial

The goal of this clinical trial is to learn if adding Shiatsu therapy to standard treatment can improve quality of life in children and adolescents with chronic pain that is not caused by inflammation. The main question it aims to answer is: Does Shiatsu therapy help improve the quality of life in children with long-lasting pain?

All participants will continue their regular treatment and will also:

* Receive a 30-minute Shiatsu session once a week for six weeks * Complete questionnaires about their quality of life and family impact before, during, and after the treatment period

The study includes about 40 participants between the ages of 10 and 18, who are already being followed at the pediatric pain and rheumatology clinics at Tel Aviv Sourasky Medical Center.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Children and adolescents aged 10-18 years

Diagnosed with non-inflammatory chronic pain syndromes

Actively followed by the Pediatric Rheumatology and/or Pediatric Pain Clinics at Tel Aviv Sourasky Medical Center (at least twice a year)

Informed consent signed by at least one legal guardian (or both guardians in cases of separated parents)

Disqualifiers

Informed consent cannot be obtained from the participant or their legal guardians

Legal guardians unable to provide informed consent

Patients with severe conditions (e.g., bone metastasis)

Patients unable to participate in Shiatsu therapy sessions

Trial design

Design model

Single group

Treatments tested in this trial

  • Shiatsu Therapy

    Behavioral

    Participants will receive one 30-minute session of Shiatsu therapy per week for 6 weeks. Therapy will be provided by trained Shiatsu practitioners under a standardized protocol developed for this study.

Treatment groups

40 Participants
are divided into 1 treatment group
Group A: Shiatsu Therapy GroupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in Pediatric Quality of Life Inventory Version 4.0 (PedsQL 4.0) Generic Core Scale Total Score

The PedsQL 4.0 Generic Core Scale is a validated questionnaire that measures health-related quality of life in children and adolescents. Participants will complete the age-appropriate version of the PedsQL. It includes 23 items across four subscales: physical, emotional, social, and school functioning. Responses are reverse-scored and transformed to a 0-100 scale. Higher scores indicate better quality of life. The change in total score from baseline to follow-up time points will be assessed.

Time frame
Baseline (Day 0), Week 3 (after the 3rd Shiatsu session), Week 6 (after the 6th Shiatsu session, end of intervention), and Week 18 (3 months post-intervention)

Secondary outcomes

1

Change in Pediatric Quality of Life Inventory Family Impact Module (PedsQL FIM) Total Score

The Pediatric Quality of Life Inventory Family Impact Module (PedsQL FIM) is a validated caregiver-reported questionnaire that assesses the impact of a child's health condition on family functioning. It includes 36 items covering physical, emotional, social, and cognitive functioning, communication, worry, daily activities, and family relationships. Responses are reverse-scored and transformed to a 0-100 scale. Higher scores indicate better family functioning and less caregiver burden. The change in total score from baseline to follow-up time points will be assessed.

Time frame
Baseline (Day 0), Week 3 (after the 3rd Shiatsu session), Week 6 (after the 6th Shiatsu session, end of intervention), and Week 18 (3 months post-intervention)
2

Change in Pain Intensity (Numerical Rating Scale, NRS)

Pain intensity will be self-reported using the Numerical Rating Scale (NRS), a validated 11-point scale ranging from 0 to 10, where 0 means "no pain" and 10 means "worst possible pain." Participants will rate their pain at each time point. The change in score from baseline to follow-up time points will be assessed.

Time frame
Baseline (Day 0), Week 3 (after the 3rd Shiatsu session), Week 6 (after the 6th Shiatsu session, end of intervention), and Week 18 (3 months post-intervention)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Tel Aviv University

Lead sponsor

Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Collaborator

Dana-Dwek Children's Hospital

Collaborator